Expanding Access and Reducing Prices for Drugs to Prevent HIV: Should Government Enforce Its Patent Rights Against the Pharmaceutical Industry?
Publication
, Journal Article
Rai, A; Gostin, L
Published in: JAMA
2020
Duke Scholars
Published In
JAMA
Publication Date
2020
Volume
323
Issue
9
Start / End Page
821 / 822
Related Subject Headings
- Pre-Exposure Prophylaxis
- Patents as Topic
- Legislation, Drug
- Humans
- Health Services Accessibility
- HIV Infections
- Government Regulation
- General & Internal Medicine
- Drug Industry
- Anti-Retroviral Agents
Citation
APA
Chicago
ICMJE
MLA
NLM
Rai, A., & Gostin, L. (2020). Expanding Access and Reducing Prices for Drugs to Prevent HIV: Should Government Enforce Its Patent Rights Against the Pharmaceutical Industry? JAMA, 323(9), 821–822.
Rai, A., and L. Gostin. “Expanding Access and Reducing Prices for Drugs to Prevent HIV: Should Government Enforce Its Patent Rights Against the Pharmaceutical Industry?” JAMA 323, no. 9 (2020): 821–22.
Rai A, Gostin L. Expanding Access and Reducing Prices for Drugs to Prevent HIV: Should Government Enforce Its Patent Rights Against the Pharmaceutical Industry? JAMA. 2020;323(9):821–2.
Rai, A., and L. Gostin. “Expanding Access and Reducing Prices for Drugs to Prevent HIV: Should Government Enforce Its Patent Rights Against the Pharmaceutical Industry?” JAMA, vol. 323, no. 9, 2020, pp. 821–22.
Rai A, Gostin L. Expanding Access and Reducing Prices for Drugs to Prevent HIV: Should Government Enforce Its Patent Rights Against the Pharmaceutical Industry? JAMA. 2020;323(9):821–822.
Published In
JAMA
Publication Date
2020
Volume
323
Issue
9
Start / End Page
821 / 822
Related Subject Headings
- Pre-Exposure Prophylaxis
- Patents as Topic
- Legislation, Drug
- Humans
- Health Services Accessibility
- HIV Infections
- Government Regulation
- General & Internal Medicine
- Drug Industry
- Anti-Retroviral Agents